// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Secular Trends and Outcome of Isolated versus Combined Type 2 Pulmonary Hypertension in Patients with End-Stage Heart Failure

A. Nasri - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Advanced heart failure

N/A

Feasibility of Exercise Hemodynamic Evaluation in the Clinical Cardiac Catheterization Laboratory

F. Valle - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Effect of Left Ventricular Assist Devices (LVAD) on Pulmonary Hypertension: A Single Center Review

P.L. Tremblay - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Frequency of Arterial Thromboembolism in Patients with Cancer: A Systematic Review

J. Yu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

VWF Production and Secretion, and Endothelial Cell Characteristics in Healthy ECFCs; Generating a Valid ex vivo Model for VWD

S. de Boer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Transcriptional Coactivators, YAP and TAZ Regulate Expression of the von Willebrand Factor Gene

E. Ghorbanpour - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

verteporfin

Polyphosphate‐induced Thrombosis is Enhanced in Mice Deficient in Histidine‐rich Glycoprotein

R. Malik - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Identification of the Histidine‐rich Glycoprotein Domain Responsible for its Inhibition of Factor XIIa

T. Truong - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Evithrom

Comparison of Factor VIII Half‐life as Determined Using Two Web‐accessible Population‐based Pharmacokinetic Applications

J. Teitel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

FVIII

Heterogeneity in Levels of FVIII and VWF Expression in Subpopulations of Human Endothelial Cells

C. Hough - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

FVIII

A Method to Quantify Alpha‐ and Beta‐Antithrombin in Plasma

H. Atkinson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Coagulation Function Tests to Measure Direct Oral Anticoagulant (DOAC) Levels: Comparison of Routine and DOAC‐specific Tests in the PAUSE Study

J. Douketis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

rivaroxaban

A Fluorescence Resonance Energy Transfer (FRET)‐Based Protein Substrate for Measuring Thrombin Activity

Y. Dai - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Protein C

Use of a Novel Assay to Measure Anti‐factor Xa Direct Oral Anticoagulant Levels in the Plasma Samples from the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

L. Di Giuseppantonio - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

rivaroxaban

Mixing Study to Establish the Diagnosis of Type II Antithrombin Deficiency: A Case Report

A. Bahabri - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Age‐adjusted D‐dimer Cutoff for the Diagnosis of Pulmonary Embolism: A Cost‐effectiveness Analysis

M. Blondon - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

N/A

Definitions, Adjudication, and Reporting of Pulmonary Embolism‐related Death in Clinical Studies: A Systematic Review

N. Kraaijpoel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

N/A

Exome Sequence Findings and Bleeding Manifestations for Uncharacterized Platelet Function Disorders with Impaired Aggregation Responses and/or Non‐syndromic Dense Granule Deficiency: Results from the Hamilton Platelet Disorder Study

J. Brunet - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Physical Activity and Treatment Adherence in Persons with Hemophilia Receiving Standard Half‐Life (SHL) vs. Extended Half‐Life (EHL) Replacement Factor VIII (FVIII): Findings from the HemACTIVE Patient Survey

M. Skinner - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Factor VIII Pharmacokinetics Associate with VWF Clearance, VWF‐FVIII Binding Activity, and Variants in the CLEC4M Gene in an Adult Hemophilia A Population

L.L. Swystun - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

rFVIII

Copyright © 2026. QuantiNova All rights reserved